Monarch Medical Technologies
About Monarch Medical Technologies
Monarch Medical Technologies has been driving innovation in insulin management technology for over 20 years. The company's mission is to better the lives of hospital personnel and their patients by delivering safe and simple personalized insulin therapy enabled by technology.
Monarch Medical Technologies is part of Glooko, a global leader in diabetes management, transforming diabetes care from hospital to home.
Monarch Medical Technologies is part of Glooko, a global leader in diabetes management, transforming diabetes care from hospital to home.
Company history and milestones
Founded in 2003 as MD Scientific, Monarch Medical Technologies developed the EndoTool glucose management system and has consistently expanded its impact in glycemic management.
EndoTool received FDA clearance in 2006, with the first implementation at Carolina's Medical Center (now part of Atrium Health).
The company was acquired by Eigen Capital in 2012, establishing Monarch Medical Technologies.
Over the years, the company has launched patented technologies such as the Estimated Residual Extracellular Insulin (EREI) calculation and EndoTool SubQ, receiving multiple FDA clearances and continually improving its system's safety and effectiveness.
In 2025, Monarch Medical Technologies was acquired by Glooko, a leading provider of remote patient monitoring and digital health solutions for diabetes.
EndoTool received FDA clearance in 2006, with the first implementation at Carolina's Medical Center (now part of Atrium Health).
The company was acquired by Eigen Capital in 2012, establishing Monarch Medical Technologies.
Over the years, the company has launched patented technologies such as the Estimated Residual Extracellular Insulin (EREI) calculation and EndoTool SubQ, receiving multiple FDA clearances and continually improving its system's safety and effectiveness.
In 2025, Monarch Medical Technologies was acquired by Glooko, a leading provider of remote patient monitoring and digital health solutions for diabetes.
Mission and vision
Vision: A world where every inpatient insulin dose is the right one.
Mission: To better the lives of hospital personnel and their patients by delivering safe and simple personalized insulin therapy, enabled by technology.
Mission: To better the lives of hospital personnel and their patients by delivering safe and simple personalized insulin therapy, enabled by technology.
Leadership team
Monarch Medical Technologies is led by an experienced executive team including CEO Charles Cornish, CFO Sharai Lavoie, Chief Medical Officer Paul Chidester, and other senior vice presidents overseeing technology, regulatory affairs, operations, marketing, and sales.
Clinical advisory board
The clinical advisory board consists of physicians with expertise in endocrinology, pulmonology, and medical research, collectively contributing more than 190 years of combined experience to support innovation and clinical solutions development.
Careers
The company is committed to innovation in insulin management, offering career opportunities to contribute to advancements in patient care. Job openings can be found at their careers page.